How Long Does Aimovig Stay in Your System?
Aimovig (erenumab-aooe) is a monoclonal antibody given as a monthly subcutaneous injection for migraine prevention. Its elimination follows first-order pharmacokinetics, with a half-life of about 28 days in healthy adults.[1] This means it takes roughly 28 days for half the drug to clear from your bloodstream after a dose.
Full clearance typically occurs after 4-5 half-lives, so Aimovig stays detectable in your system for 4-5 months (112-140 days) post-injection.[1][2] Steady-state levels build up after 4 monthly doses, where exposure increases about 20% from the first dose.[1]
Factors Affecting Clearance Time
Age, body weight, and kidney/liver function have minimal impact on Aimovig's half-life.[1] No dosage adjustments are needed for mild-to-moderate hepatic or renal impairment. In severe cases, data is limited, so consult your doctor. Antibodies against erenumab can develop in 6-12% of patients, potentially speeding clearance by reducing effectiveness, though it doesn't alter half-life directly.[1][3]
Detection in Tests or Missed Doses
Routine blood tests rarely check for Aimovig, but its long half-life means it lingers during drug screens for biologics (e.g., in clinical trials). If you miss a dose, effects may persist 1-2 months due to accumulation, but headaches could return sooner—resume as soon as possible.[2][4]
What Happens If You Stop Aimovig?
No withdrawal syndrome occurs; migraines may resume within weeks as levels drop below therapeutic thresholds (around 2-3 half-lives, or 8-12 weeks).[3][4] No rebound effects reported in trials.
[1]: Aimovig Prescribing Information (Amgen)
[2]: Drugs.com - Aimovig Pharmacokinetics
[3]: FDA Label - Erenumab
[4]: Medscape - Aimovig Dosing